Abstract:Background: It is generally recognized that genetic metabolic disorders can result in neurological symptoms such as seizures, developmental delay, and intellectual disability. Heterogeneous clinical presentations make the diagnosis challenging. Case presentation: In this case report, we present a unique and complex genetic disorder observed in a female patient who exhibited three pathogenic gene variants in the KCNT1, ACADM, and CHD4 genes. The convergence of these variants resulted in a multifaceted clinical presentation characterized by severe seizures of combined focal and generalized onset, metabolic dysfunction, and neurodevelopmental abnormalities. The identification and functional characterization of these gene variants shed light on the intricate interplay between these genes and the patient's phenotype. EEG revealed an epileptiform abnormality which presented in the inter-ictal period from the left frontal-central area and in the ictal period from the left mid-temporal area. The brain MRI revealed volume loss in the posterior periventricular area and parietal parenchyma, myelin destruction with no sign of hypoxic involvement, and left dominant enlargement of the lateral ventricles secondary to loss of central parenchyma. The patient was diagnosed through exome sequencing with Sifrim-Hitz-Weiss syndrome, development and epileptic encephalopathy-14, and medium-chain acyl-CoA dehydrogenase deficiency. An antiseizure medication regimen with valproic acid, levetiracetam, phenobarbital, and clonazepam was initiated. However, this led to only partial control of the seizures. Conclusion: Clinical follow-up of the patient will further define the clinical spectrum of KCNT1, ACADM, and CHD4 gene variants. It will also determine the long-term efficacy of the treatment of seizures and the development of precision medicine for epilepsy syndromes due to gain-of-function variants. Special emphasis should be put on the role and importance of large-scale genomic testing in understanding and diagnosing complex phenotypes and atypical epileptic syndromes.

Cherry-red Spot:A Case Report of Sialidosis I and Literature Review

Sialidosis type 1 without cherry-red spots: a case report and literature review

Compound Heterozygous Mutations in the Neuraminidase 1 Gene in Type 1 Sialidosis: A Case Report and Review of Literature

Late-onset isolated sulfite oxidase deficiency: a case report and literature review

Neurophysiolgical implications in sialidosis type 1: a case report

Case report and literature review: Novel compound heterozygous <i>FIG4</i> variants causing both of peripheral and central nervous system defects

Heterozygous structural variation mimicking homozygous missense mutations in NEU1 associated with presenting clinical signs in eyes alone.

Case Report and Literature Review: Novel Compound Heterozygous FIG4 Variants Causing Both of Peripheral and Central Nervous System Defects

Infantile epileptic spasm syndrome as a new NR2F1 gene phenotype

Progressive myoclonic ataxia as an initial symptom of typical type I sialidosis with NEU1 mutation

Case Report: Novel CNGA3 compound heterozygous variants cause achromatopsia in three patients from a family

Genetic Variant Reanalysis Reveals a Case of Sandhoff Disease with Onset of Infantile Epileptic Spasm Syndrome

Unique clinical and electrophysiological features in the peripheral nerve system in patients with sialidosis – a case series study

Two cases of type I sialidosis and a literature review

A Novel SACS Variant Identified in a Chinese Patient: Case Report and Review of the Literature

A Chinese family with cat eye syndrome and abnormality of eye movement: First case report

Novel variants of SYNGAP1 associated epileptic encephalopathy: two cases report and literature review

Severe dilated cardiomyopathy as an unusual clinical presentation in an infant with sialidosis type II

Case report: Diagnosis of a patient with Sifrim-Hitz-Weiss syndrome, development and epileptic encephalopathy-14, and medium chain acyl-CoA dehydrogenase deficiency

Case report: Novel SCN4A variant associated with a severe congenital myasthenic syndrome/myopathy phenotype

A clinical and electrophysiological case study of a child with a novel frame shift mutation in the CACNA1F and missense variation of RIMS1 genes